Evaluating the effects of thermotherapy on cutaneous leishmaniasis

Evaluating the Efficacy of thermotherapy in treatment of patients with cutaneous leishmaniasis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903183862N5

Enrollment

Registered

2010-06-08

Start date

2007-10-16

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous leishmaniasis. Cutaneous leishmaniasis

Interventions

Thermotherapy: 4 to 6 weeks (3 times weekly - ten minutes each time).

Treatment - Other

Thermotherapy: 4 to 6 weeks (3 times weekly - ten minutes each time)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: confirmed cutaneous leishmaniasis by direct smear, less than 6 months of clinical duration, ulcer size less than 1 cm that limits topical application thermotherapy, signing of inform consent form for using this treatment modalities. Exclusion criteria: presence of lesion in sensitive sites to thermotherapy, patients who under simultaneous treatment for cutaneous leishmaniasis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Lesion healing. Timepoint: weekly. Method of measurement: measuring the size of induration and ulcer by caliper.	—

Secondary

Measure	Time frame
Side effect. Timepoint: weekly. Method of measurement: clinical evaluation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadis Yousefzadeh

Research center for skin disease and cutaneous leishmaniasis

hadis_yousefzadeh@yahoo.com+98 51 1841 0135

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026